I now have comprehensive content from Guyton covering all the major renal clinical cases. Let me compile the full answer.
All Clinical Cases from Guyton - Renal Physiology
(Guyton and Hall Textbook of Medical Physiology, 14th Edition)
CLINICAL CASE 1: Acute Kidney Injury (AKI)
Definition & Classification
AKI is an abrupt decrease in kidney function resulting in accumulation of waste products. Guyton classifies it into three categories:
| Type | Origin | Examples |
|---|
| Prerenal AKI | Decreased blood supply to kidneys | Heart failure, hemorrhage, burns, sepsis |
| Intrarenal AKI | Abnormalities within the kidney | Glomerulonephritis, tubular necrosis, toxins |
| Postrenal AKI | Obstruction of urinary tract | Kidney stones, prostatic hypertrophy, ureteral obstruction |
CASE 1A: Prerenal AKI
Causes of Decreased Renal Blood Flow:
| Category | Examples |
|---|
| Intravascular volume depletion | Hemorrhage (trauma, surgery, GI bleed, postpartum), diarrhea, vomiting, burns |
| Cardiac failure | Myocardial infarction, valvular damage |
| Peripheral vasodilation + hypotension | Anaphylactic shock, anesthesia, sepsis |
| Primary renal hemodynamic abnormality | Renal artery stenosis, embolism, renal vein thrombosis |
Pathophysiology:
- Normal renal blood flow ~1100 mL/min (~22% of cardiac output)
- As RBF falls → ↓ GFR → ↓ Na⁺ filtered → ↓ tubular reabsorption → ↓ O₂ consumption
- This protective reduction allows the kidney to tolerate reduced blood flow down to ~20-25% of normal without major cellular damage
- Below this level → tubular epithelial cells become hypoxic → cell death → intrarenal AKI
- Oliguria (urine output < fluid intake) develops when RBF is significantly reduced
- Anuria (complete cessation of urine output) may occur with very severe reduction
Clinical key: If the cause is corrected before permanent damage occurs, prerenal AKI is fully reversible. If ischemia persists for hours, it evolves into intrarenal AKI.
CASE 1B: Intrarenal AKI - Acute Glomerulonephritis
Causes of Intrarenal AKI:
Small vessel / glomerular injury: Vasculitis, polyarteritis nodosa, glomerulonephritis
Tubular injury: Acute tubular necrosis (ischemia, nephrotoxins - aminoglycosides, heavy metals, contrast dye)
Interstitial injury: Pyelonephritis, allergic interstitial nephritis (NSAIDs, penicillin)
Acute Glomerulonephritis:
- Most common cause: abnormal immune reaction 1-3 weeks after infection elsewhere in the body (classically Group A beta-hemolytic Streptococcus - post-streptococcal GN)
- Mechanism: antigen-antibody complexes deposit in glomerular capillaries → inflammatory reaction → ↓ GFR
- Features: hematuria, proteinuria, reduced urine output, edema, hypertension
- If the inflammation subsides, most patients recover; if severe/persistent → CKD
CASE 1C: Postrenal AKI
- Obstruction anywhere from the calyces to the bladder outlet
- Most common cause: kidney stones (calcium, urate, or cystine precipitation)
- Obstruction → ↑ Bowman capsule hydrostatic pressure → ↓ net filtration pressure → ↓ GFR → hydronephrosis
- Relief of obstruction usually restores GFR
CLINICAL CASE 2: Chronic Kidney Disease (CKD) and Uremia
Causes of CKD
| Category | Examples |
|---|
| Metabolic disorders | Diabetes mellitus (most common), obesity, amyloidosis |
| Hypertension | Nephrosclerosis |
| Immunological | Glomerulonephritis, polyarteritis nodosa, SLE (lupus erythematosus) |
| Infections | Pyelonephritis, tuberculosis |
| Primary tubular | Nephrotoxins (analgesics, heavy metals) |
| Urinary tract obstruction | Renal calculi, prostatic hypertrophy, urethral stricture |
| Congenital | Polycystic kidney disease, renal hypoplasia |
Key principle: Despite the variety of causes, the end result is always the same - progressive loss of functional nephrons.
The kidney can maintain relatively normal blood electrolyte concentrations and body fluid volumes until nephron number falls to less than 20-25% of normal. Below this, clinical uremia develops.
The Vicious Cycle of CKD → ESRD
- Surviving nephrons hypertrophy and vasodilate to compensate
- This causes hyperfiltration in remaining nephrons → ↑ glomerular pressure
- Over time, high pressure damages surviving glomeruli → glomerular sclerosis
- This triggers further nephron loss → the cycle continues
- Ultimately leads to end-stage renal disease (ESRD)
Uremia - Effects of Renal Failure on Body Fluids
As renal function deteriorates and GFR approaches zero with continued food/water intake:
| Effect | Mechanism |
|---|
| Generalized edema | Water and salt retention (↓ urinary excretion) |
| Metabolic acidosis | Failure to excrete H⁺ and regenerate bicarbonate |
| ↑ BUN, creatinine, uric acid (azotemia) | Failure to excrete metabolic end products of protein |
| Hyperkalemia | Failure to excrete K⁺; life-threatening arrhythmias |
| Hyperphosphatemia | ↓ phosphate excretion → renal osteodystrophy |
| Hypocalcemia | ↓ renal activation of Vitamin D → ↓ Ca²⁺ absorption |
| Hypertension | Na⁺/water retention → ↑ blood volume |
| Anemia | ↓ erythropoietin production |
Isosthenuria - An early clinical sign of CKD: the kidney loses its ability to concentrate OR dilute urine. Urine osmolality approaches the osmolality of the glomerular filtrate (~300 mOsm/L, specific gravity ~1.010). Useful clinical test: water restriction for 12+ hours - inability to concentrate urine is evidence of CKD.
CLINICAL CASE 3: Nephrotic Syndrome
Definition: Massive proteinuria (>3.5 g/day) due to increased glomerular capillary permeability, causing loss of 30-50 g of plasma protein per day in the urine.
Pathophysiology:
- Glomerular capillary permeability ↑ → plasma proteins (especially albumin) leak into filtrate
- Plasma protein concentration falls to <1/3 of normal → plasma colloid osmotic pressure falls markedly
- Capillaries throughout the body filter excess fluid into tissues → massive edema
- Reduced plasma volume activates RAAS and sympathetic nervous system
- Kidneys retain Na⁺ and water → blood volume partially restored
- But proteins remain diluted → plasma oncotic pressure remains low → fluid continues leaking into tissues
- Vicious cycle: more Na⁺/water retention → more dilution of plasma proteins → more edema
Features:
- Massive pitting edema (anasarca)
- Proteinuria >3.5 g/day
- Hypoalbuminemia
- Hyperlipidemia and lipiduria (compensatory liver protein synthesis makes lipoproteins)
- Frothy urine
Causes: Minimal change disease (most common in children), membranous nephropathy, diabetic nephropathy, focal segmental glomerulosclerosis
CLINICAL CASE 4: Renal Interstitial Nephritis and Pyelonephritis
Pyelonephritis
- Bacterial infection of the renal interstitium, most commonly from E. coli (fecal origin)
- Route of infection: bloodstream, or more commonly ascending infection via ureters from bladder
Predisposing conditions:
- Incomplete bladder emptying - residual urine allows bacteria to multiply
- Urinary tract obstruction - impairs flushing of bacteria
- Vesicoureteral reflux - urine propelled back up ureters during micturition, carrying bacteria to the renal pelvis
Sequence: Cystitis (bladder infection) → vesicoureteral reflux → ascending to renal pelvis → pyelonephritis
Clinical effects:
- Primarily affects the medulla initially → impaired countercurrent mechanism → inability to concentrate urine (earliest sign)
- Long-standing pyelonephritis: progressive tubular, glomerular, and interstitial damage throughout the kidney → CKD
CLINICAL CASE 5: Tubular Transport Disorders
Bartter Syndrome
- Autosomal-recessive mutation in Na-K-2Cl transporter in the thick ascending limb of the loop of Henle
- Results in: impaired Na⁺ reabsorption → salt wasting → volume depletion → RAAS activation → hypokalemia, metabolic alkalosis, hyper-reninemia, hyperaldosteronism
- Blood pressure is normal or low (despite high renin/aldosterone) because volume depletion counteracts vasoconstriction
- Treatment: replace NaCl and K⁺; NSAIDs (reduce prostaglandin-mediated vasodilation); spironolactone (aldosterone antagonist)
Gitelman Syndrome
- Autosomal-recessive mutation in thiazide-sensitive NaCl co-transporter in the distal tubule
- Similar to Bartter syndrome but milder: salt wasting, volume depletion, RAAS activation, hypokalemia, metabolic alkalosis
- Also associated with hypomagnesemia (impaired Mg²⁺ reabsorption in distal tubule)
- Treatment: NaCl + K⁺ + Mg²⁺ supplementation; spironolactone
Liddle Syndrome
- Autosomal-dominant gain-of-function mutation in amiloride-sensitive epithelial Na⁺ channel (ENaC) in distal and collecting tubules
- Results in: excessive Na⁺ reabsorption → hypertension, metabolic alkalosis, hypokalemia
- Resembles primary hyperaldosteronism BUT: renin is low, aldosterone is low (because Na⁺ retention suppresses the RAAS)
- Treatment: amiloride (directly blocks ENaC); NOT spironolactone (because aldosterone is not elevated)
CLINICAL CASE 6: Renal Artery Stenosis - Two-Kidney Goldblatt Hypertension
Scenario: Stenosis of ONE renal artery with a normal contralateral kidney.
Mechanism:
- ↓ Pressure in ischemic kidney → ↑ Renin secretion → ↑ Angiotensin II
- Angiotensin II → vasoconstriction → ↑ arterial pressure
- ↑ Arterial pressure → normal kidney increases Na⁺/water excretion (pressure natriuresis)
- The ischemic kidney cannot respond to increased pressure (has low perfusion pressure)
- Net effect: sustained hypertension
- Elevated angiotensin II also causes the normal kidney to retain salt/water → adds to hypertension
Treatment: Revascularization (angioplasty, stenting) or ACE inhibitors/ARBs
Warning: ACE inhibitors in bilateral renal artery stenosis can cause AKI by removing the angiotensin II-driven efferent constriction that maintains GFR.
CLINICAL CASE 7: Treatment of Renal Failure - Dialysis
Indications for Dialysis
- Severe AKI (temporary, until kidney function recovers)
- ESRD (permanent) - over 800,000 patients in the USA are on ESRD therapy
Principles of Dialysis (Artificial Kidney)
- Blood passes through minute channels bounded by a thin semipermeable membrane
- On the other side of the membrane is a dialysate solution with a composition similar to normal plasma
- Small molecules (urea, creatinine, electrolytes) diffuse from blood into dialysate down concentration gradients
- Normal plasma electrolytes are maintained in the dialysate so they are NOT removed
- Larger molecules (proteins) are too big to pass through the membrane
Limitations of Dialysis vs. Transplantation
- Dialysis cannot replace all kidney functions (erythropoietin production, Vitamin D activation, renin-angiotensin regulation)
- Health of dialysis patients remains significantly impaired
- Kidney transplantation restores function more completely and patients live longer with fewer complications
- ~25,000 kidney transplantations are performed per year in the USA
- Requires lifelong immunosuppressive therapy → risk of infections and some cancers
All content from Guyton and Hall Textbook of Medical Physiology, 14th Edition, Chapters 26-32.